Mike Prime is currently the Director of Drug Design at Recursion, a position they have held since 2024. Previously, they served as the Director of Drug Design at Exscientia from 2021 to 2024 and worked as a Senior Scientist and Project Leader at Evotec from 2001 to 2002. They also contributed as a Medicinal Chemist at Tularik Ltd between 2002 and 2005. Mike earned a PhD in Organic Chemistry from the University of Birmingham, following a BSc with first-class honors in Chemistry with Bio-organic Chemistry from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices